Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$399,234
-$46,053 QoQ
Shares Held
3,160
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,497
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Blume Capital Management, Inc. holds $20,264,751 across 12 Drug Manufacturers - General names. GILD ranks #4 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,083 | $11,449,729 | |
| 2 | PFE |
Pfizer Inc
|
241,130 | $5,806,410 | |
| 3 | SNY |
Sanofi
|
47,681 | $2,034,071 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
3,160 | $399,234 | |
| 5 | AMGN |
Amgen Inc
|
530 | $191,923 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,400 | $179,900 | |
| 7 | LLY |
ELI LILLY & Co
|
60 | $71,965 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,054 | $60,731 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $399,234 | 3,160 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $445,287 | 3,195 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $392,154 | 3,195 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $382,395 | 3,445 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $390,927 | 3,526 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $395,872 | 3,533 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $325,142 | 3,520 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $295,116 | 3,520 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $241,507 | 3,520 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $257,840 | 3,520 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $285,155 | 3,520 | Shares | Sole | 2024-05-02 | |
| 2023-09-30 | $269,784 | 3,600 | Shares | Sole | 2024-05-02 | |
| 2023-06-30 | $447,006 | 5,800 | Shares | Sole | 2024-05-02 | |
| 2023-03-31 | $481,226 | 5,800 | Shares | Sole | 2024-05-02 | |
| 2022-12-31 | $575,967 | 6,709 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $423,131 | 6,859 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $412,272 | 6,670 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $331,671 | 5,579 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $259,871 | 3,579 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $241,611 | 3,459 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $258,844 | 3,759 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $249,407 | 3,859 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $183,519 | 3,150 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $211,686 | 3,350 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $257,749 | 3,350 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $250,446 | 3,350 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||